144 related articles for article (PubMed ID: 31625007)
1. The epithelial cadherin -160C/A polymorphism is associated with decreased risk of colorectal cancer: a case-control study.
Li W; Xiao D; Wu H; Xu L
Clin Exp Med; 2020 Feb; 20(1):73-78. PubMed ID: 31625007
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin (CDH1) gene -160C/A polymorphism and the risk of colorectal cancer: A meta-analysis involving 17,291 subjects.
Ye CC; Wang J
J Gene Med; 2021 Oct; 23(10):e3370. PubMed ID: 34097324
[TBL] [Abstract][Full Text] [Related]
3. Association between the Epithelial Cadherin - 160C/A Polymorphism and Colorectal Cancer Risk: Evidence from a Meta-Analysis.
Sun N; Chen J; Hu G; Chen X; Jiang J; Zhang L; Wu H
Crit Rev Eukaryot Gene Expr; 2017; 27(4):347-354. PubMed ID: 29283329
[TBL] [Abstract][Full Text] [Related]
4. The CDH1-160C>A polymorphism is a risk factor for colorectal cancer.
Pittman AM; Twiss P; Broderick P; Lubbe S; Chandler I; Penegar S; Houlston RS
Int J Cancer; 2009 Oct; 125(7):1622-5. PubMed ID: 19569232
[TBL] [Abstract][Full Text] [Related]
5. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.
Govatati S; Singamsetty GK; Nallabelli N; Malempati S; Rao PS; Madamchetty VK; Govatati S; Kanapuram R; Narayana N; Bhanoori M; Kassetty K; Nallanchakravarthula V
Tumour Biol; 2014 Dec; 35(12):12059-67. PubMed ID: 25146682
[TBL] [Abstract][Full Text] [Related]
6. Association of clinicopathological features with E-cadherin (CDH1) gene-160 C>A promoter polymorphism in Turkish colorectal cancer patients.
Bahadir A; Eral G; Budak M; Shimamoto F; Korpinar MA; Erdamar S; Tuncel H
J Cancer Res Ther; 2019; 15(1):26-31. PubMed ID: 30880750
[TBL] [Abstract][Full Text] [Related]
7. CDH1 polymorphisms and haplotypes in sporadic diffuse and intestinal gastric cancer: a case-control study based on direct sequencing analysis.
Chu CM; Chen CJ; Chan DC; Wu HS; Liu YC; Shen CY; Chang TM; Yu JC; Harn HJ; Yu CP; Yang MH
World J Surg Oncol; 2014 Mar; 12():80. PubMed ID: 24684952
[TBL] [Abstract][Full Text] [Related]
8. Association between E-cadherin (CDH1) polymorphisms and papillary thyroid carcinoma risk in Han Chinese population.
Wang YX; Zhao L; Wang XY; Liu CM; Yu SG
Endocrine; 2012 Jun; 41(3):526-31. PubMed ID: 22194161
[TBL] [Abstract][Full Text] [Related]
9. Association between E-cadherin (CDH1) polymorphisms and pancreatic cancer risk in Han Chinese population.
Zhao L; Wang YX; Xi M; Liu SL; Zhang P; Luo LL; Liu MZ
Int J Clin Exp Pathol; 2015; 8(5):5753-60. PubMed ID: 26191293
[TBL] [Abstract][Full Text] [Related]
10. Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes.
Grünhage F; Jungck M; Lamberti C; Berg C; Becker U; Schulte-Witte H; Plassmann D; Rahner N; Aretz S; Friedrichs N; Buettner R; Sauerbruch T; Lammert F
Int J Colorectal Dis; 2008 Feb; 23(2):147-54. PubMed ID: 17960397
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin and metalloproteinase-1 and -7 polymorphisms in colorectal cancer.
de Lima JM; de Souza LG; da Silva ID; Forones NM
Int J Biol Markers; 2009; 24(2):99-106. PubMed ID: 19634113
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
[TBL] [Abstract][Full Text] [Related]
13. The E-cadherin (CDH1) -160C>A polymorphism associated with gastric cancer among Asians but not Europeans.
Wang Q; Gu D; Wang M; Zhang Z; Tang J; Chen J
DNA Cell Biol; 2011 Jun; 30(6):395-400. PubMed ID: 21214416
[TBL] [Abstract][Full Text] [Related]
14. Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas.
Zhang XF; Wang YM; Ge H; Cao YY; Chen ZF; Wen DG; Guo W; Wang N; Li Y; Zhang JH
Dis Esophagus; 2008; 21(1):21-9. PubMed ID: 18197935
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin (CDH1) gene promoter polymorphism and the risk of colorectal cancer : a meta-analysis.
Wang Y; Yang H; Li L; Wang H; Zhang C; Xia X
Int J Colorectal Dis; 2012 Feb; 27(2):151-8. PubMed ID: 21997289
[TBL] [Abstract][Full Text] [Related]
16. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
Liang J; Li Y; Wang N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
[TBL] [Abstract][Full Text] [Related]
17. Association of CD44 gene rs187115 polymorphism with colorectal cancer risk and prognosis in Chinese Han population: a case-control study.
Wan Q; Zhang D; Zhou Q; Li M; Wang Y; Song Y; Xu T
Aging (Albany NY); 2019 Nov; 11(21):9616-9625. PubMed ID: 31682231
[TBL] [Abstract][Full Text] [Related]
18. The CDH1 -160C/A polymorphism is associated with breast cancer: evidence from a meta-analysis.
Ma YY; Wu WQ; Liu ZC; Yu XF; Guo K; He QW; Jiang SB; Shao QS; Tao HQ; Huang DS
World J Surg Oncol; 2016 Jun; 14(1):169. PubMed ID: 27349965
[TBL] [Abstract][Full Text] [Related]
19. Lack of Association between the CDH1 -160C>A Polymorphism and Risk of Gastrointestinal Cancer - a Meta-Analysis.
Sahami-Fard MH; Yazd EF; Khazaei Z; Neamatzadeh H
Asian Pac J Cancer Prev; 2016; 17(5):2415-21. PubMed ID: 27268607
[TBL] [Abstract][Full Text] [Related]
20. The -160C>a polymorphism in E-cadherin is associated with the risk of nephrolithiasis.
Tan M; Xia S; Zhang Q; Zhu J; Bao E
PLoS One; 2013; 8(9):e73109. PubMed ID: 24023817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
